Hangzhou, China

Youping Wang

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Introduction

Youping Wang is an accomplished inventor based in Hangzhou, China, known for his significant contributions to the field of tumor immunotherapy. With a keen focus on developing advanced methodologies, he has dedicated his efforts to enhancing the effectiveness of cancer treatments through innovative approaches.

Latest Patents

Youping Wang holds a patent titled "System and Method for Screening and Assessing Agents for Tumor Immunotherapy." This patent outlines a comprehensive and systematic approach for effectively screening and evaluating agents designed for tumor immunotherapy. The innovative system assesses the effects of target cells, non-target cells, and tumor infiltration, paving the way for improved safety and efficacy in cancer therapies.

Career Highlights

Wang's career includes a significant role at Adlai Nortye Biopharma Co., Ltd., a company recognized for its dedication to developing cutting-edge biopharmaceuticals. His work at the company revolves around enhancing treatment options for cancer patients, making notable strides in research and development in immunotherapy.

Collaborations

Throughout his career, Youping Wang has collaborated with several professionals in the field, including esteemed colleagues Nanhai He and Yang Lu. These collaborations foster an environment of innovation and knowledge sharing, ultimately contributing to the advancement of immunotherapeutic solutions.

Conclusion

Youping Wang exemplifies the spirit of innovation in the medical field. His groundbreaking patent highlights the potential for advancements in tumor immunotherapy, showcasing his dedication to improving patient outcomes through scientific exploration and collaboration. With continued efforts and further collaboration, Wang is set to make more impactful contributions to the biopharmaceutical industry in the future.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…